Literature DB >> 20361382

Sclerosing mesenteritis, a rare cause of a retroperitoneal tumor.

Peter Kornprat1, Bernadette Liegl-Atzwanger, Horst Portugaller, Gerwin A Bernhardt, Hans-Jörg Mischinger.   

Abstract

Sclerosing mesenteritis is a chronic and extremely rare inflammatory process that predominantly affects the small bowel mesentery. However, the peripancreatic region, the omentum and the retroperitoneum can also be involved. The etiology and pathogenesis of the disease are as yet unknown, but autoimmune disorders, previous abdominal surgery, trauma, ischemia and drugs could play a role. The clinical picture is nonspecific and varies from asymptomatic to diffuse abdominal complaints. Radiologic work-up and histologic evaluation of a biopsy specimen usually do not reveal typical findings and therefore establishment of the correct diagnosis is challenging. Owing to the rarity of the disease, there is no consensus on optimal pharmaceutical treatment and most patients are treated empirically. Surgical therapy is limited to biopsies for histologic confirmation of the tumor and management of complications. We report a case of a 51-year-old man with a large retroperitoneal mass. Magnetic resonance angiography showed a 9.7 x 7.7 x 5.9 cm tumor above the aortic bifurcation with encasement of the aorta and the vena cava. CT-guided biopsy was inconclusive but surgical biopsy provided a histologic diagnosis of sclerosing mesenteritis. The operative and postoperative course was uneventful and therapy with prednisolone and azathioprine was started. At 6 months' follow-up, the patient was in good condition and asymptomatic. Sclerosing mesenteritis, though a rare entity, should be included in the differential diagnosis when a patient presents with a mesenterial or retroperitoneal tumor.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20361382     DOI: 10.1007/s00508-010-1351-z

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  20 in total

1.  Treatment of sclerosing mesenteritis with corticosteroids and azathioprine.

Authors:  A Bala; S P Coderre; D R Johnson; V Nayak
Journal:  Can J Gastroenterol       Date:  2001-08       Impact factor: 3.522

Review 2.  The CT appearances of sclerosing mesenteritis and associated diseases.

Authors:  S Y J Wat; S Harish; A Winterbottom; A K Choudhary; A H Freeman
Journal:  Clin Radiol       Date:  2006-08       Impact factor: 2.350

3.  Are tumefactive lesions classified as sclerosing mesenteritis a subset of IgG4-related sclerosing disorders?

Authors:  T S Chen; E A Montgomery
Journal:  J Clin Pathol       Date:  2008-08-04       Impact factor: 3.411

Review 4.  An unusual presentation of sclerosing mesenteritis as pneumoperitoneum: case report with a review of the literature.

Authors:  Sumita Chawla; Satheesh Yalamarthi; Irshad A Shaikh; Veena Tagore; Paul Skaife
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

5.  Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process.

Authors:  J K ORMOND
Journal:  J Urol       Date:  1948-06       Impact factor: 7.450

Review 6.  From the archives of the AFIP: benign fibrous tumors and tumorlike lesions of the mesentery: radiologic-pathologic correlation.

Authors:  Angela D Levy; Jordi Rimola; Anupamjit K Mehrotra; Leslie H Sobin
Journal:  Radiographics       Date:  2006 Jan-Feb       Impact factor: 5.333

7.  A pilot study of thalidomide for patients with symptomatic mesenteric panniculitis.

Authors:  P M Ginsburg; E D Ehrenpreis
Journal:  Aliment Pharmacol Ther       Date:  2002-12       Impact factor: 8.171

8.  Sclerosing mesenteritis: clinical features, treatment, and outcome in ninety-two patients.

Authors:  Salma Akram; Darrell S Pardi; John A Schaffner; Thomas C Smyrk
Journal:  Clin Gastroenterol Hepatol       Date:  2007-05       Impact factor: 11.382

9.  Sclerosing mesenteritis as a rare cause of abdominal pain and intraabdominal mass: a cases report and review of the literature.

Authors:  Guo-Li Gu; Shi-Lin Wang; Xue-Ming Wei; Li Ren; De-Chang Li; Fu-Xian Zou
Journal:  Cases J       Date:  2008-10-16

10.  Detection of MDM2 gene amplification or protein expression distinguishes sclerosing mesenteritis and retroperitoneal fibrosis from inflammatory well-differentiated liposarcoma.

Authors:  Joshua Weaver; John R Goldblum; Sondra Turner; Raymond R Tubbs; Wei-Lein Wang; Alexander Jf Lazar; Brian P Rubin
Journal:  Mod Pathol       Date:  2008-10-03       Impact factor: 7.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.